ASHP Therapeutic Position Statement on the Use of Antipsychotic Medications in the Treatment of Adults with Schizophrenia and Schizoaffective Disorder
Date
2020Journal
American Journal of Health-System PharmacyPublisher
Oxford University PressType
Article
Metadata
Show full item recordIdentifier to cite or link to this item
http://hdl.handle.net/10713/14536ae974a485f413a2113503eed53cd6c53
10.1093/ajhp/zxaa303
Scopus Count
Collections
Related articles
- ASHP therapeutic position statement on the use of second-generation antipsychotic medications in the treatment of adults with psychotic disorders.
- Authors: Noel JM, American Society of Health-System Pharmacists.
- Issue date: 2007 Apr 15
- A Study of the Impact of Cannabis on Doses of Discharge Antipsychotic Medication in Individuals with Schizophrenia or Schizoaffective Disorder.
- Authors: Babatope T, Chotalia J, Elkhatib R, Mohite S, Shah J, Goddu S, Patel RA, Aimienwanu OR, Patel D, Makanjuola T, Okusaga OO
- Issue date: 2016 Dec
- Recent trends in antipsychotic combination therapy of schizophrenia and schizoaffective disorder: implications for state mental health policy.
- Authors: Clark RE, Bartels SJ, Mellman TA, Peacock WJ
- Issue date: 2002
- The role of second-generation antipsychotics in the treatment of psychotic disorders.
- Authors: Jackson CW
- Issue date: 2007 Apr 15
- Aripiprazole in schizophrenia and schizoaffective disorder: A review.
- Authors: Stip E, Tourjman V
- Issue date: 2010